Division of Rheumatology, Department of Internal Medicine, School of Medicine, Marmara University, Istanbul, Turkey.
Division of Rheumatology, Numune Education and Research Hospital, Ankara, Turkey.
J Vasc Surg Venous Lymphat Disord. 2021 Nov;9(6):1451-1459. doi: 10.1016/j.jvsv.2021.02.007. Epub 2021 Feb 20.
Deep vein thrombosis (DVT) of the lower extremities is the most common form of vascular involvement in Behçet disease (BD), frequently leading to post-thrombotic syndrome (PTS) as a disabling complication. We have described the clinical characteristics and predictors of PTS presence among patients with BD and lower extremity DVT. We also used venous Doppler ultrasound (US) examinations in our assessment.
Patients with BD (n = 205; 166 men, 39 women; age 39 ± 9.5 years) and a history of DVT were investigated. The Villalta scale was used to assess the presence and severity of PTS. Doppler US examinations were performed within 1 week of the clinical evaluation. The total number of vessels with reflux, thrombi, recanalization, and collateral vessels were calculated.
Of the 205 patients with BD, 62% had had PTS and 18% had had severe PTS. Patients with PTS had had greater reflux (P = .054) and thrombosis (P = .02) scores compared with patients without PTS. Treatment with anticoagulation (AC), immunosuppressive (IS) therapy, or AC combined with IS drugs did not affect the occurrence of PTS. However, patients treated with IS therapy, with or without AC drugs, had a decreased incidence of severe PTS compared with the AC-only group (P = .017). Patients treated with AC plus IS agents also had increased collateral scores compared with patients treated with only IS drugs. Interferon-α use seemed to provide better recanalization scores compared with azathioprine only (1.0 [range, 0-14] vs 2.5 [range, 0-10]; P = .010).
Patients with BD and DVT have a high risk of developing severe PTS. IS treatment decreases the development of severe PTS. AC therapy might influence the course of PTS by increasing the collateral scores, and the use of interferon-α also increased recanalization scores. Routine assessment with Doppler US examinations could be helpful in the prediction of severe PTS.
下肢深静脉血栓形成(DVT)是白塞病(BD)最常见的血管受累形式,常导致血栓后综合征(PTS)作为一种致残性并发症。我们描述了 BD 合并下肢 DVT 患者 PTS 存在的临床特征和预测因素。我们还在评估中使用了静脉多普勒超声(US)检查。
研究了 205 例(166 例男性,39 例女性;年龄 39±9.5 岁)有 DVT 病史的 BD 患者。采用 Villalta 量表评估 PTS 的存在和严重程度。多普勒 US 检查在临床评估后 1 周内进行。计算反流、血栓、再通和侧支血管的总血管数。
在 205 例 BD 患者中,62%有 PTS,18%有严重 PTS。与无 PTS 的患者相比,有 PTS 的患者反流(P=0.054)和血栓(P=0.02)评分更高。抗凝(AC)治疗、免疫抑制(IS)治疗或 AC 联合 IS 药物治疗并不影响 PTS 的发生。然而,与仅用 AC 药物治疗的患者相比,同时使用 IS 药物治疗或不用 AC 药物治疗的患者,严重 PTS 的发生率降低(P=0.017)。同时使用 AC 和 IS 药物的患者,侧支评分也高于仅使用 IS 药物的患者。与单独使用硫唑嘌呤相比,使用干扰素-α似乎能提供更好的再通评分(1.0[范围,0-14] vs 2.5[范围,0-10];P=0.010)。
BD 合并 DVT 患者发生严重 PTS 的风险较高。IS 治疗可降低严重 PTS 的发生。AC 治疗可能通过增加侧支评分影响 PTS 的病程,而使用干扰素-α也可增加再通评分。常规使用多普勒 US 检查有助于预测严重 PTS。